Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen B Liggett

Showing results (101-110 of 132) with videos related to

Pageof 14
Sort By:
BMC Medical Genetics|October 25, 2008
Multiple interactions between the alpha 2C- and beta1-adrenergic receptors influence heart failure survivalSharon L R Kardia, Reagan J Kelly, Mehdi A Keddache, et al.
The Journal of Allergy and Clinical Immunology|April 10, 2022
Clinical and molecular implications of RGS2 promoter genetic variation in severe asthmaJuan Carlos Cardet, Donghwa Kim, Eugene R Bleecker, et al.
Medrxiv : the Preprint Server for Health Sciences|September 18, 2025
β<sub>1</sub>- and β<sub>2</sub>-adrenergic Receptor Haplotypes Regulate Therapeutic Responses to Placebo and the Biased Ligand β-blocker BucindololIan A Carroll, Dobromir Slavov, Eric R Jonas, et al.
JACC. Heart Failure|October 26, 2013
Prevention of atrial fibrillation by bucindolol is dependent on the beta₁389 Arg/Gly adrenergic receptor polymorphismRyan G Aleong, William H Sauer, Gordon Davis, et al.
Clinical and Translational Science|February 26, 2011
Hypertrophy-associated polymorphisms ascertained in a founder cohort applied to heart failure risk and mortalityAfshin Parsa, Yen-Pei C Chang, Reagan J Kelly, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2020
β-Arrestin2 oligomers impair the clearance of pathological tau and increase tau aggregatesJung-A A Woo, Tian Liu, Cenxiao C Fang, et al.
Journal of Personalized Medicine|March 3, 2018
A Genome-Wide Association Study of Idiopathic Dilated Cardiomyopathy in African AmericansHuichun Xu, Gerald W Dorn, Amol Shetty, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2021
Identification and characterization of an atypical Gαs-biased β<sub>2</sub>AR agonist that fails to evoke airway smooth muscle cell tachyphylaxisDonghwa Kim, Alina Tokmakova, Lauren K Lujan, et al.
Circulation. Genomic and Precision Medicine|October 26, 2018
Dose Response of β-Blockers in Adrenergic Receptor Polymorphism GenotypesKishan S Parikh, Mona Fiuzat, Gordon Davis, et al.
Circulation|November 19, 2003
Common genomic response in different mouse models of beta-adrenergic-induced cardiomyopathyVinciane Gaussin, James E Tomlinson, Christophe Depre, et al.
Pageof 14

Showing results (101-110 of 132) with videos related to

Sort By:
Pageof 14
BMC Medical Genetics|October 25, 2008
Multiple interactions between the alpha 2C- and beta1-adrenergic receptors influence heart failure survivalSharon L R Kardia, Reagan J Kelly, Mehdi A Keddache, et al.
The Journal of Allergy and Clinical Immunology|April 10, 2022
Clinical and molecular implications of RGS2 promoter genetic variation in severe asthmaJuan Carlos Cardet, Donghwa Kim, Eugene R Bleecker, et al.
Medrxiv : the Preprint Server for Health Sciences|September 18, 2025
β<sub>1</sub>- and β<sub>2</sub>-adrenergic Receptor Haplotypes Regulate Therapeutic Responses to Placebo and the Biased Ligand β-blocker BucindololIan A Carroll, Dobromir Slavov, Eric R Jonas, et al.
JACC. Heart Failure|October 26, 2013
Prevention of atrial fibrillation by bucindolol is dependent on the beta₁389 Arg/Gly adrenergic receptor polymorphismRyan G Aleong, William H Sauer, Gordon Davis, et al.
Clinical and Translational Science|February 26, 2011
Hypertrophy-associated polymorphisms ascertained in a founder cohort applied to heart failure risk and mortalityAfshin Parsa, Yen-Pei C Chang, Reagan J Kelly, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2020
β-Arrestin2 oligomers impair the clearance of pathological tau and increase tau aggregatesJung-A A Woo, Tian Liu, Cenxiao C Fang, et al.
Journal of Personalized Medicine|March 3, 2018
A Genome-Wide Association Study of Idiopathic Dilated Cardiomyopathy in African AmericansHuichun Xu, Gerald W Dorn, Amol Shetty, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2021
Identification and characterization of an atypical Gαs-biased β<sub>2</sub>AR agonist that fails to evoke airway smooth muscle cell tachyphylaxisDonghwa Kim, Alina Tokmakova, Lauren K Lujan, et al.
Circulation. Genomic and Precision Medicine|October 26, 2018
Dose Response of β-Blockers in Adrenergic Receptor Polymorphism GenotypesKishan S Parikh, Mona Fiuzat, Gordon Davis, et al.
Circulation|November 19, 2003
Common genomic response in different mouse models of beta-adrenergic-induced cardiomyopathyVinciane Gaussin, James E Tomlinson, Christophe Depre, et al.
Pageof 14